NEW
Stock Screener with Intrinsic Value
Bristol-Myers Squibb Company (BMY)
Last Price$56.3(0.2%)
Market Cap$114.2B
$47.4B
+5.6% YoY
($7,258.0M)
N/A
$43.3B
Net Debt to FCF - 3.1x
$13.8B
29.1% margin
BMY Income Statement
BMY Income Statement Overview
Crunching data... Almost there!
BMY Income statement key metrics
Crunching data... Almost there!
BMY Balance Sheet
BMY Balance Sheet Overview
Crunching data... Almost there!
BMY Balance Sheet Metrics
Crunching data... Almost there!
BMY Cash Flow Statement
BMY Cash Flow Statement Overview
Crunching data... Almost there!
BMY Cash Flow Statement key metrics
Crunching data... Almost there!
BMY Financials
Crunching data... Almost there!
FAQ
What is the Bristol-Myers Squibb Company (BMY) revenue?
The Bristol-Myers Squibb Company (BMY) revenue is $45.0B, reflecting a year-over-year (YoY) growth of -2.5% YoY.
What is the Bristol-Myers Squibb Company (BMY) Net Income?
The Bristol-Myers Squibb Company (BMY) Net Income is $8,025.0M, showcasing a YoY growth of +26.8% YoY.
What is Bristol-Myers Squibb Company (BMY) net debt?
What is the Bristol-Myers Squibb Company (BMY) Free Cash Flow (FCF)?
The Bristol-Myers Squibb Company (BMY) Free Cash Flow (FCF) stands at $12.7B, accounting for a 28.1% margin.